D.E. Shaw & Co’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.66M Hold
346,900
﹤0.01% 2413
2025
Q4
$3.64M Hold
346,900
﹤0.01% 2578
2025
Q3
$3.59M Hold
346,900
﹤0.01% 2506
2025
Q2
$3.57M Buy
+346,900
New +$3.52M ﹤0.01% 2286

Other funds holding TDAC

D.E. Shaw & Co's TDAC Position: Q1 2026 in Review

D.E. Shaw & Co held its Translational Development Acquisition Corp (TDAC) position steady in Q1 2026 at 346,900 shares worth $3.66M. The position accounts for ﹤0.01% of the portfolio, ranked #2413.

D.E. Shaw & Co first reported a position in TDAC in Q2 2025 and has held it in 4 quarters since. 48 funds tracked by Wall St. Rank hold TDAC as of Q1 2026.

  • D.E. Shaw & Co held 346,900 shares of Translational Development Acquisition Corp worth $3.66M as of Q1 2026.
  • D.E. Shaw & Co left its Translational Development Acquisition Corp share count unchanged in Q1 2026.
  • Translational Development Acquisition Corp made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #2413 holding.
  • D.E. Shaw & Co first reported a position in Translational Development Acquisition Corp in Q2 2025 and has held it in 4 quarters since.
  • 48 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.